Zurcher Kantonalbank Zurich Cantonalbank cut its position in Cantel Medical Corp. (NYSE:CMD) by 92.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,317 shares of the company’s stock after selling 55,549 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Cantel Medical were worth $407,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Globeflex Capital L P bought a new position in Cantel Medical during the second quarter valued at $114,000. LS Investment Advisors LLC bought a new stake in shares of Cantel Medical in the 2nd quarter worth about $172,000. World Asset Management Inc bought a new stake in shares of Cantel Medical in the 3rd quarter worth about $224,000. Waldron LP bought a new stake in shares of Cantel Medical in the 3rd quarter worth about $232,000. Finally, Ingalls & Snyder LLC bought a new stake in shares of Cantel Medical in the 3rd quarter worth about $235,000. 84.98% of the stock is owned by hedge funds and other institutional investors.
CMD has been the subject of several analyst reports. Needham & Company LLC restated a “hold” rating on shares of Cantel Medical in a report on Friday, September 1st. Zacks Investment Research upgraded shares of Cantel Medical from a “sell” rating to a “hold” rating in a report on Tuesday, August 8th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company. Cantel Medical has a consensus rating of “Hold” and a consensus price target of $91.67.
Cantel Medical Corp. (CMD) traded down $2.89 during midday trading on Wednesday, reaching $100.49. 208,500 shares of the company’s stock were exchanged, compared to its average volume of 146,027. The company has a quick ratio of 1.49, a current ratio of 2.41 and a debt-to-equity ratio of 0.24. The stock has a market cap of $4,321.89, a P/E ratio of 49.70 and a beta of 1.24. Cantel Medical Corp. has a 1-year low of $69.21 and a 1-year high of $108.00.
Cantel Medical (NYSE:CMD) last posted its earnings results on Thursday, September 28th. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.52 by $0.02. The business had revenue of $205.50 million for the quarter, compared to the consensus estimate of $200.32 million. Cantel Medical had a net margin of 9.27% and a return on equity of 17.60%. The company’s revenue for the quarter was up 14.8% compared to the same quarter last year. equities research analysts expect that Cantel Medical Corp. will post 2.34 earnings per share for the current year.
The firm also recently announced a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Shareholders of record on Wednesday, January 17th will be given a dividend of $0.085 per share. This is an increase from Cantel Medical’s previous Semi-Annual dividend of $0.07. The ex-dividend date is Tuesday, January 16th. This represents a yield of 0.17%. Cantel Medical’s dividend payout ratio (DPR) is 8.19%.
In other Cantel Medical news, Chairman Charles M. Diker sold 20,500 shares of the firm’s stock in a transaction dated Wednesday, October 4th. The shares were sold at an average price of $99.15, for a total transaction of $2,032,575.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Mark N. Diker sold 7,000 shares of the firm’s stock in a transaction dated Tuesday, October 3rd. The shares were sold at an average price of $98.90, for a total transaction of $692,300.00. The disclosure for this sale can be found here. Insiders have sold a total of 36,368 shares of company stock worth $3,576,028 in the last three months. Insiders own 12.30% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/12/06/zurcher-kantonalbank-zurich-cantonalbank-has-407000-stake-in-cantel-medical-corp-cmd.html.
About Cantel Medical
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.